54.15€
0.00€ (0.00%)
End-of-day quote: 08/12/2022
XTRA:BAYN

Bayer (BAYN)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide.

If you are interested in BAYN stock information, you might also be interested in competitors like NasdaqGS:COST.

The market capitalization of Bayer is currently at 53.20€ B. This places it among the high capitalized companies.

The book value reported in the balance sheet results in a P/B ratio of 1.4.

With one share of Bayer investors achieved a dividend of 2.00€. This results in a good dividend yield of 3.69%. In the last 13 years, the annual dividend has risen constantly.

For the risk analysis, the high beta factor should be noted, which is currently at a value of 1.15. The price of the stock XTRA:BAYN is therefore subject to relatively strong fluctuations in relation to the overall market.

For Wall Street analysts, a price target of 67.79€ is currently considered realistic.

XTRA:BAYN has a 52 week range of 43.91€ - 67.99€ and is currently trading around 54.15€.

The low short sale ratio indicated that the value might increase in the foreseeable future.

5
Neutral
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
9.7
Market Cap
53.20B
LT Debt/Cap
0.05%
Price-to-book Ratio
1.40
Earnings
11/08/2022
Dividend
2.00€
Div Yld
3.69%
Dividend Growth
13 Years
Beta
1.15
Short Interest
0.00%
Forecast 1Y
31.95%
Analyst Price Target
67.79€
LTG 5Y
-2.32%
52 week range
43.91€ - 67.99€
Country